Lumen Therapeutics LLC entered the industry of Commercial Medical Research in 2003 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541712, which describes it as a Commercial Medical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Paul Mcgrane by calling (650) 450-4439 during business hours. You can also write to the business’ Single Location at 325 Sharon Park Drive # 753, Menlo Park, California CA 94025. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Lumen Therapeutics LLC |
| Representative: | Paul Mcgrane |
| Place of Business: | 325 Sharon Park Drive # 753, Menlo Park, CA 94025 |
| Contact Number: | (650) 450-4439 |
| Type of Service: | Commercial Medical Research |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2003 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Lumen Therapeutics LLC is a company operating from San Mateo, California providing professional Commercial Medical Research and relevant B2B variables. It was founded in 2003 and registered with the SIC code 8731 as Commercial Medical Research, and with the NAICS code 541712 as Commercial Medical Research.
With a current employee count of 1 to 4, Lumen Therapeutics LLC has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Paul Mcgrane at (650) 450-4439 for related queries, or to locate its Single Location using the coordinates 37.42424,-122.197451.
The Single Location can also be found at the street address 325 Sharon Park Drive # 753 in Menlo Park, California 94025 and can be engaged online through the company website at , the company Twitter , and Facebook page .